Chiron Settles Suit Over Inhaled Drug
- Share via
Emeryville, Calif.-based Chiron Corp. said it reached a settlement with Respiratory Disease Network, a group of pharmacies owned by SourceCF Inc., over a version of Chiron’s antibiotic tobramycin for use in an inhaler.
The settlement requires the pharmacies to attach a disclaimer to their formulation, saying it’s not approved by the Food and Drug Administration, the company said. No financial terms were disclosed.
From Bloomberg News
* The Justice Department asked a federal appeals court to reconsider a ruling by a three-judge panel that barred the government from seeking $280 billion in past profits from cigarette makers. The department filed a motion with the U.S. District Court of Appeals for the D.C. Circuit, asking the full court to review last month’s decision.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
